Edition:
United States

Jounce Therapeutics Inc (JNCE.OQ)

JNCE.OQ on NASDAQ Stock Exchange Global Select Market

19.66USD
10:45am EDT
Change (% chg)

$-0.12 (-0.61%)
Prev Close
$19.78
Open
$19.58
Day's High
$19.83
Day's Low
$19.21
Volume
12,673
Avg. Vol
112,451
52-wk High
$29.29
52-wk Low
$11.05

Chart for

About

Jounce Therapeutics, Inc. is a clinical stage immunotherapy company. The Company is engaged in transforming the treatment of cancer by developing therapies that enable the immune system to attack tumors and provide long lasting benefits to patients. Through the use of its Translational Science Platform, Jounce first focuses on... (more)

Overall

Beta: --
Market Cap(Mil.): $629.69
Shares Outstanding(Mil.): 32.39
Dividend: --
Yield (%): --

Financials

  JNCE.OQ Industry Sector
P/E (TTM): -- 185.16 33.25
EPS (TTM): -0.54 -- --
ROI: -7.93 -0.71 13.13
ROE: -34.49 -2.76 14.96

BRIEF-Jounce Therapeutics Files For Mixed Shelf Of Up To $250 Mln

* JOUNCE THERAPEUTICS INC FILES FOR MIXED SHELF OF UP TO $250 MILLION - SEC FILING

Mar 08 2018

BRIEF-Jounce Therapeutics Q4 Loss Per Share $0.29

* JOUNCE THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS

Mar 08 2018

BRIEF-Jounce Therapeutics reports Q3 loss $0.13/shr

* Jounce Therapeutics reports third quarter 2017 financial results

Nov 13 2017

Competitors

Earnings vs. Estimates